The relevance of APN ligands (NGR (Asn-Gly-Arg) sequence containing peptides) in tumor targeting was discovered in in vitro screens using phage-display libraries set up to identify non-RGD (-Arg-Gly-Asp-) integrin binding motives [6–8]. The gene discussed is RTN4R; the disease is neoplasm.